Further information

The OxidoResist project aims to develop a technology to overcome drug resistance in cancer. The OxidoResist technology will apply the innovative single-cell proteomics and modern AI-based bioinformatics to discover which FDA-approved drugs will overcome resistance when combined with the anticancer drug under study. We will develop a universal pipeline for the discovery of optimal drug combinations that overcome resistance to target-specific therapies.

The project aims to develop and introduce two new products on the market:

1) Medicines against cancer with a new mechanism of action

2) Service platform

The project aims to develop a technology to overcome anticancer drug resistance. The technology will apply the innovative single cell proteomics and modern AI-based bioinformatics to discover which FDA-approved drugs will overcome resistance in combination with anti-cancer drugs under study. We will develop a universal pipeline (joining top labs, AI-based bioinformatics, chemoinformatics, and network modeling) for the discovery of optimal drug combinations that overcome resistance to target-specific therapies.